FBD[Home]   [About]   [Services]   [Software]   [Contacts]   [News]
     
    Drug Design Consultancy
    FBD has extensive experience working with
    • established CAMD (Computer Aided Molecular Design)teams
    • and providing an outsourced facility for chemistry and biology groups
    for Target Validation, Lead Generation and Lead Optimisation projects.

    In-house proprietary software, Bodil, provides new cutting-edge techniques for Homology studies. Where required these can be complemented by structural determination through Protein X-ray crystallography.

    Using Structure Based Drug Design techniques, pharmacophore models are developed to explain the protein-ligand interaction and the binding mode of the drug target. These results are suitable for use in virtual screening against corporate databases, or comprehensive collections of commercially available compounds.

    Custom library design can provide alternative core structures for chemists to develop providing access to patentable areas of IP or increasing the binding affinity by log points. FBD can also provide chemical samples with which to test the hypothesis generated and provide some real datapoints to minimise the iterative process.
     
     
    back
     
    Solutions for Molecular Discovery
    FBD Ltd., P.O.Box 122, FI-20521 Turku, Finland
    fax. +358 2 215 3280, e-mail: firstname.lastname@fbd.fi